Cellectis SA
PAR:ALCLS

Watchlist Manager
Cellectis SA Logo
Cellectis SA
PAR:ALCLS
Watchlist
Price: 2.21 EUR -7.92% Market Closed
Market Cap: 159.3m EUR

Wall Street
Price Targets

ALCLS Price Targets Summary
Cellectis SA

Wall Street analysts forecast ALCLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALCLS is 6.63 EUR with a low forecast of 6.57 EUR and a high forecast of 6.83 EUR.

Lowest
Price Target
6.57 EUR
197% Upside
Average
Price Target
6.63 EUR
200% Upside
Highest
Price Target
6.83 EUR
209% Upside
Cellectis SA Competitors:
Price Targets
INCY
Incyte Corp
3% Downside
ABBV
Abbvie Inc
5% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
26% Upside
PHIL
Philogen SpA
30% Upside
PHARM
Pharming Group NV
408% Upside
PHM
Pharma Mar SA
13% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
11% Upside
196170
Alteogen Inc
9% Upside

Revenue
Forecast

Revenue Estimate
Cellectis SA

For the last 13 years the compound annual growth rate for Cellectis SA's revenue is 10%. The projected CAGR for the next 3 years is 9%.

10%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cellectis SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Cellectis SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALCLS's stock price target?
Price Target
6.63 EUR

According to Wall Street analysts, the average 1-year price target for ALCLS is 6.63 EUR with a low forecast of 6.57 EUR and a high forecast of 6.83 EUR.

What is Cellectis SA's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Cellectis SA's revenue is 10%. The projected CAGR for the next 3 years is 9%.

Back to Top